Brief: Sino Biopharmaceutical Says Application For Market Launch Of "Obeticholic Acid Tablets" Accepted By NMPA
01/02/2024 10:30
Feb 1 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* APPLICATION FOR MARKET LAUNCH OF "OBETICHOLIC ACID
TABLETS"
FILED AND ACCEPTED BY CHINA NMPA
Source text for Eikon: ID:n11058342-1
Further company coverage: 1177.HK
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up